[The characteristics of thrombolytic therapy in myocardial infarct in middle-aged and elderly patients].
Teslia
A N
AN
Kolesnikov
S A
SA
Mikhaĭlov
A A
AA
D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017052:Hospital Mortality; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D012189:Retrospective Studies; D012426:Russia / Q000453:epidemiology; D013300:Streptokinase / Q000009:adverse effects / Q000627:therapeutic use*; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000379:methods* / Q000706:statistics & numerical data; D013997:Time Factors
D005343:Fibrinolytic Agents; D013300:Streptokinase